Report - Oriol Puig Sant Josep 2015 Hospital de Bellvitge joint IAEA, EANM, and SNMMI oractical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. J. J. Zaknum

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form